BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6169362)

  • 1. Cytokinetic effects of anthralin on psoriatic keratinocytes.
    Pullmann H; Enderer K; Steigleder GK
    Br J Dermatol; 1981 Aug; 105 Suppl 20():55-6. PubMed ID: 6169362
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultrastructural changes in psoriatic epidermis following anthralin treatment.
    Wilborn WH; Montes LF
    J Cutan Pathol; 1974; 1(3):132-50. PubMed ID: 4377841
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical signs of response to treatment in psoriasis--a cell kinetic and histological assessment using the IBAS II image analyser.
    Newton JA; Camplejohn RS; Bowyer C; Graham RM; McGibbon DM; Wright NA
    Clin Exp Dermatol; 1985 Jan; 10(1):36-40. PubMed ID: 3987084
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study.
    Gottlieb SL; Heftler NS; Gilleaudeau P; Johnson R; Vallat VP; Wolfe J; Gottlieb AB; Krueger JG
    J Am Acad Dermatol; 1995 Oct; 33(4):637-45. PubMed ID: 7545705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T; Nishioka K
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of psoriasis vulgaris: gentleness to the entire psoriatic skin and the use of low concentrations of anthralin.
    Brody I
    Br J Dermatol; 1981 Aug; 105 Suppl 20():109-10. PubMed ID: 7284255
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dynamics of regression of psoriatic changes under the effect of cygnoline in the light of ultrastructural studies. II. Psoriatic changes after treatment with cygnoline].
    Szczeklik-Franek A; Rubisz-BrzeziƄska JA; Grzybek H
    Patol Pol; 1979; 30(1):43-8. PubMed ID: 503597
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antipsoriatic effect of dithranol (anthralin). 2].
    Raab W
    Hautarzt; 1975 Sep; 26(9):456-9. PubMed ID: 1102494
    [No Abstract]   [Full Text] [Related]  

  • 9. Mast cell alterations in chronic psoriasis vulgaris: response to low-strength anthralin treatment. A transmission electron microscopic study.
    Brody I
    Ups J Med Sci; 1986; 91(1):1-16. PubMed ID: 3716018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial ring-phenomenon of keratinocytes in psoriasis vulgaris after dithranol therapy.
    Klug H; Schulze P
    J Cutan Pathol; 1987 Aug; 14(4):212-6. PubMed ID: 2442211
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of anthralin on stratum corneum antigenicity and polymorphonuclear leukocyte chemotaxis.
    Langner A; Chorzelski TP; Fraczykowska M; Beutner EH; Jablonska S
    Br J Dermatol; 1981 Aug; 105 Suppl 20():62-3. PubMed ID: 7284269
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antipsoriatic effect of dithranol (anthralin). 1].
    Raab W
    Hautarzt; 1975 Sep; 26(9):452-5. PubMed ID: 1184389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of anthralin in skin during treatment.
    Juhlin L; Schroot B
    Acta Derm Venereol Suppl (Stockh); 1985; 120():27-9. PubMed ID: 3869415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar].
    Schauder S; Mahrle G
    Z Hautkr; 1985 Jun; 60(11):875-83. PubMed ID: 3160177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthralin therapy for psoriasis.
    Statham BN; Ryatt KS; Rowell NR
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 1):303-4. PubMed ID: 6480932
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental contribution to the dithranol-brown problem.
    Wiegrebe W; Plumier E; Mayer KK; Runne U; Schultz-Amling W; Rosmarinowski J; Safar GJ; Kubka KD
    Arch Dermatol Res; 1985; 277(2):153-5. PubMed ID: 3985673
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in the use of anthralin.
    Seville RH
    J Am Acad Dermatol; 1981 Sep; 5(3):319-21. PubMed ID: 7263977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in the mode of action of anthralin in the treatment of psoriasis.
    Br J Dermatol; 1981 Aug; 105 Suppl 20():1-114. PubMed ID: 7284252
    [No Abstract]   [Full Text] [Related]  

  • 19. Anthralin therapy for psoriasis. A new look at an old compound.
    Gorsulowsky DC; Voorhees JJ; Ellis CN
    Arch Dermatol; 1985 Dec; 121(12):1509-11. PubMed ID: 4062331
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined 1-hour therapy of psoriasis using anthralin and UV light].
    Schauder S; Mahrle G
    Hautarzt; 1982 Apr; 33(4):206-9. PubMed ID: 7096083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.